Cypress Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.41M Sell
29,456
-134
-0.5% -$6.67K 1.61% 23
2018
Q4
$1.54M Buy
29,590
+181
+0.6% +$9.72K 2.11% 12
2018
Q3
$1.83M Sell
29,409
-120
-0.4% -$7.12K 1.92% 17
2018
Q2
$1.63M Sell
29,529
-393
-1% -$21.2K 1.77% 20
2018
Q1
$1.89M Hold
29,922
2.05% 14
2017
Q4
$1.83M Buy
29,922
+393
+1% +$24.6K 1.76% 19
2017
Q3
$1.88M Buy
29,529
+7,380
+33% +$431K 3.04% 7
2017
Q2
$1.23M Sell
22,149
-12,502
-36% -$680K 1.44% 18
2017
Q1
$1.88M Sell
34,651
-374
-1% -$20.5K 0.86% 26
2016
Q4
$2.05M Buy
35,025
+1,780
+5% +$97.3K 0.93% 26
2016
Q3
$1.79M Sell
33,245
-479
-1% -$30.8K 0.81% 29
2016
Q2
$2.48M Buy
33,724
+400
+1% +$28.3K 1.23% 17
2016
Q1
$2.13M Buy
33,324
+8
+0% +$505 0.97% 23
2015
Q4
$2.29M Buy
33,316
+2,604
+8% +$172K 1.16% 21
2015
Q3
$1.82M Buy
30,712
+691
+2% +$43.8K 0.98% 20
2015
Q2
$2M Buy
+30,021
New +$1.98M 1.17% 20

Other funds holding BMY

Cypress Wealth Advisors's BMY Position: Q1 2019 in Review

Cypress Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.45% in Q1 2019, selling an estimated $6.67K and leaving 29,456 shares worth $1.41M. The position accounts for 1.61% of the portfolio, ranked #23.

Cypress Wealth Advisors first reported a position in BMY in Q2 2015 and has held it in 16 quarters since. The position peaked at $2.48M in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Cypress Wealth Advisors held 29,456 shares of Bristol-Myers Squibb worth $1.41M as of Q1 2019.
  • Cypress Wealth Advisors sold 134 Bristol-Myers Squibb shares in Q1 2019, an estimated $6.67K.
  • Bristol-Myers Squibb made up 1.61% of Cypress Wealth Advisors's portfolio in Q1 2019, its #23 holding.
  • Cypress Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 16 quarters since.
  • Cypress Wealth Advisors's Bristol-Myers Squibb position peaked at $2.48M in Q2 2016.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Cypress Wealth Advisors's 13F filing for Q1 2019, filed 17 May 2019.